Key Takeaways
- Recruiting participants for clinical trials, especially in rare diseases, significantly challenges due to small patient populations and traditional methods.
- Patient advocacy in clinical trials can improve recruitment and engagement by fostering early partnerships with patients to design studies around their needs.
- Engaging patients early leads to better trial designs, higher enrollment rates, and improved retention, while avoiding costly delays and protocol amendments.
- Patient Advocacy Strategies (PAS) bridge the gap between life science companies and patient communities, enhancing trial design and communication strategies.
- These strategies deliver value to patients by aligning trials with their needs and to sponsors by improving outcomes and reducing timelines.
The Strongest Clinical Trials Are Built With Patients, Not Just For Them
Clinical trials are the backbone of life science treatments, providing the data needed to bring new & innovative therapies to market. However, recruiting participants for these trials is a persistent challenge, particularly when it comes to rare disease studies. This article explores proven, data-driven strategies for improving recruitment and engagement through patient advocacy.
The Recruitment Challenge in Clinical Trials
Recruiting participants for clinical trials is notoriously difficult. Many trials struggle to find enough eligible volunteers, leading to delays and increased costs. This issue is exacerbated in rare disease studies, where patient populations are small and scattered globally. The rarer the disease, the harder it is to find participants who meet the specific criteria needed for a study.
Limitations of Traditional Recruitment Methods
Contract Research Organizations (CROs) are often employed to manage recruitment efforts. However, they frequently fall short in rare disease contexts due to their reliance on conventional recruitment strategies that may not resonate with niche patient communities. This inefficiency can result in prolonged timelines and unmet recruitment targets.
The Power and Value of Early Patient Engagement
One proactive and effective strategy to address these challenges is forging authentic partnerships with patients from the earliest stages of drug development, before clinical trials begin. Engaging patients at the pre-clinical stage helps ensure that studies are designed with their needs embedded, leading to accelerated enrollment and stronger retention rates.
Enlisting the support of patients and integrating their insights into study development earns trust with targeted patient advocates and their communities. This trust is critical to long-term success as a program progresses toward commercial launch. Aligning with patients enables a trusted army of champions for science who will amplify study awareness, celebrate data readouts and support regulatory strategies and activity.
As highlighted in an article published in the Therapeutic Innovation & Regulatory Science Journal by Dr. Bennet Levitan and Dr. Ken Getz of the Tufts Center for the Study of Drug Development, early engagement with patient communities resulted in avoidance of protocol amendments and other delays. The authors looked at a $100,000 investment in patient activities to inform the trial, including patient advisory panels, patient experience surveys, and trial awareness educational resources. The study found that the impact of such partnerships with patients led to a greater than 500X return on investment due to trials staying on schedule, avoiding time-sensitive amendments and accelerated regulatory approval.
Patient Advocacy Strategies (PAS) Can Help
Patient Advocacy Strategies (PAS) plays a crucial role in bridging the gap between life science companies and patient communities. By harmonizing engagement efforts and amplifying the patient voice, PAS helps create actionable insights that benefit both patients and biopharma companies. Here’s how PAS works:
- Community Engagement: PAS builds trusted, high-tough relationships with patient advocacy groups, individual patients and other stakeholders to ensure their perspectives are integrated into trial design and execution.
- Patient-Centric Trial Design: By focusing on the needs and preferences of patients, PAS helps design trials that are more appealing and accessible to potential participants.
- Effective Communication Strategies: Tailored messaging and outreach campaigns informed by patients, PAS improves awareness and understanding of clinical trials among target populations.
- Co-developed educational content: Working with the very patients your study is targeting, we create live action patient story videos and a litany of other educational resources that speaks to patients to elevate awareness, accelerate enrollment and strengthen retention to optimize study design and drive study success.
Delivering Value to Patients and Sponsors
The strategies employed by PAS not only enhance recruitment but also deliver significant value to both patients and sponsors. Patients benefit from trials that are more aligned with their needs and priorities, while sponsors see improved trial outcomes and reduced timelines.
Get Involved: Do it the right way. Partner with Us
If you’re interested in learning more about how Patient Advocacy Strategies can optimize your clinical trial efforts, we invite you to reach out for more information. Together, we can create a more inclusive and right-sized clinical trial strategy that exceeds the needs of all stakeholders.
